British pharmaceutical giant GlaxoSmithKline will plead guilty and pay a fine of $3 billion to settle the biggest health care fraud case in US history.
The US Justice Department charged GlaxoSmithKline for promoting its antidepressant drugs Paxil and Wellbutrin as treatments for conditions for which they had not been approved by regulators, such as depression in adolescents, according to Agence France-Presse.
The company also held back data and made unsubstantiated claims about its diabetes drug Avandia, CNN Money reported. | GlobalPost
- GlaxoSmithKline fined $3 billion in US - RTÉ News
- GlaxoSmithKline fined $3-billion in largest health fraud settlement in U.S. - The Globe and Mail